Sign in

CIK 0001390478 · Non-accelerated filer<br>Smaller reporting company

SELLAS Life Sciences Group, Inc.

Sign in to watch
Ticker
SLS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
6462005278
Business address
7 TIMES SQUARE, SUITE 2503, NEW YORK, NY, 10036
Former names
GALENA BIOPHARMA, INC., Galena Biopharma, Inc., RXI PHARMACEUTICALS CORP
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2017-01-17 Knapp Thomas J General Counsel Grant or award · Stock Option (right to buy) +5,000 5,000
2017-01-17 Burns John Thomas Vice President, Finance Grant or award · Stock Option (right to buy) +15,000 15,000
2016-11-01 Ghiglieri Stephen F Chief Financial Officer Grant or award · Stock Option (right to buy) +1,000,000 1,000,000
2016-10-25 Knapp Thomas J General Counsel Grant or award · Stock Option (right to buy) +102,000 102,000
2016-07-14 Nisi Rudolph Director Grant or award · Stock Option (right to buy) +100,000 100,000
2016-07-14 Hillsberg Sanford Director Grant or award · Stock Option (right to buy) +100,000 100,000
2016-07-14 Ashton William Director Grant or award · Stock Option (right to buy) +100,000 100,000
2016-07-14 GALLIKER STEPHEN S Director Grant or award · Stock Option (right to buy) +100,000 100,000
2016-07-14 GRAY MARY ANN Director Grant or award · Stock Option (right to buy) +100,000 100,000
2016-07-14 Einhorn Irving M. Director Grant or award · Stock Option (right to buy) +100,000 100,000
2016-07-14 Chin Richard Director Grant or award · Stock Option (right to buy) +100,000 100,000
2016-07-01 Nejadnik Bijan Chief Medical Officer Other acquisition +8,503 $0.40 $3K 8,503
2016-07-01 SCHWARTZ MARK W. President & CEO Other acquisition +8,503 $0.40 $3K 439,978
2016-07-01 Burns John Thomas Principal Accounting Officer Other acquisition +8,503 $0.40 $3K 10,899
2016-06-01 Dunlap Ryan Former Chief Financial Officer Option exercise +31,250 $1.75 $55K 49,952
2016-06-01 Dunlap Ryan Former Chief Financial Officer Option exercise +65,625 $1.85 $121K 115,577
2016-06-01 Dunlap Ryan Former Chief Financial Officer Option exercise +30,000 $1.71 $51K 145,577
2016-06-01 Dunlap Ryan Former Chief Financial Officer Sale −126,875 $2.18 $277K 18,702
2016-06-01 Dunlap Ryan Former Chief Financial Officer Option exercise · Stock Option −31,250 95,625
2016-06-01 Dunlap Ryan Former Chief Financial Officer Option exercise · Stock Option −65,625 30,000

Page 11 of 17 · 324 trades